🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate th...
Status
Active Not Recruiting
Location
Usa Mitchell Cancer Institute /ID# 269661
Start Date
2023-03-15
Trial ID
NCT05445778
Treatments Being Tested
This Phase 3 study is designed to compare the efficacy and safety of mirvet...
Status
Completed
Location
University of Alabama at Birmingham (UAB) GYN Oncology
Start Date
2019-12-31
Trial ID
NCT04209855
Treatments Being Tested
Epithelial ovarian cancer, which includes fallopian tube and primary perito...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT07687602
The proposed study design is a single arm Phase II trial to document the fe...
Status
Recruiting
Location
University of Alabama at Birmingham Womens & Infants Center
Start Date
2021-05-27
Trial ID
NCT04606914
Treatments Being Tested
This is a Phase 3, open label, randomized study designed to compare the saf...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2016-03-02
Trial ID
NCT02631876
Treatments Being Tested
The purpose of this study is to test mirvetuximab soravtansine (IMGN853) in...
Status
Completed
Location
University of Kansas Medical Center Research Institute
Start Date
2012-06-28
Trial ID
NCT01609556
Treatments Being Tested
Cancer is a condition where cells in a specific part of body grow and repro...
Status
Recruiting
Location
University of Alabama at Birmingham (UAB) Hospital /ID# 274793
Start Date
2025-11-21
Trial ID
NCT06890338
Treatments Being Tested
Ovarian cancer is a lethal disease with an estimated 310,000 new cases and ...
Status
Recruiting
Location
UC San Diego Health - Moores Cancer Center /ID# 277574
Start Date
2025-11-13
Trial ID
NCT07059845
Treatments Being Tested
The intention of the study is to demonstrate superiority of AZD5335 versus ...
Status
Recruiting
Location
Research Site
Start Date
2025-12-29
Trial ID
NCT07218809
This phase I trial studies the side effects and best dose of mirvetuximab s...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2018-07-12
Trial ID
NCT03552471